In this issue:
Tamoxifen in male breast cancer
Pembrolizumab + neoadjuvant chemotherapy
Adjuvant chemotherapy in TNBC
Abemaciclib, fulvestrant and trastuzumab for mBC
QoL comparable for T-DM1 vs trastuzumab
DCIS and risk of invasive breast cancer
Breast cancer incidence and mortality with HRT
Non-inferiority of shorter breast radiotherapy
Mammography screening decision aid
Please login below to download this issue (PDF)